Stereotaxis (STXS) Retained Earnings (2010 - 2026)
Stereotaxis' (STXS) quarterly Retained Earnings came in at -$589.2 million in Q1 2026, down 3.83% year-on-year from -$612.7 million in Q1 2025, and down 1.0% on a QoQ basis from -$583.4 million in Q4 2025.
Stereotaxis (STXS) Retained Earnings (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Retained Earnings data on file, last reported at -$589.2 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 3.83% year-over-year to -$589.2 million in Q1 2026; TTM through Mar 2026 was -$589.2 million, a 3.83% decrease from a year earlier, with the FY2025 full-year figure at -$583.4 million, down 202.72% from the prior year.
- Retained Earnings for Q1 2026 stood at -$589.2 million, down from -$583.4 million in the prior quarter.
- Over the last five years, Retained Earnings for STXS reached as high as $584.2 million in Q3 2025 and fell as low as -$589.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$32.1 million across 5 years, with a median of -$502.8 million in 2022.
- Across the five-year window, Retained Earnings surged 208.98% in 2022 and slumped 202.72% in 2025, its largest moves.
- Year by year, Retained Earnings stood at $543.4 million in 2022, then slumped by 198.94% to -$537.7 million in 2023, then jumped by 205.63% to $567.9 million in 2024, then slumped by 202.72% to -$583.4 million in 2025, then fell by 1.0% to -$589.2 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$589.2 million in Q1 2026, -$583.4 million in Q4 2025, and $584.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 22.11 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 6.84 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -1.76 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 122.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -24.91 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.98 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 1.81 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.55 Bn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -589.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -589.23 Mn |
| Dec 31, 2025 | -583.37 Mn |
| Sep 30, 2025 | 584.22 Mn |
| Jun 30, 2025 | -571.40 Mn |
| Mar 31, 2025 | -567.50 Mn |
| Dec 31, 2024 | 567.93 Mn |
| Sep 30, 2024 | -554.21 Mn |
| Jun 30, 2024 | -548.02 Mn |
| Mar 31, 2024 | 556.88 Mn |
| Dec 31, 2023 | -537.68 Mn |
| Sep 30, 2023 | 551.48 Mn |
| Jun 30, 2023 | 548.78 Mn |
| Mar 31, 2023 | -522.31 Mn |
| Dec 31, 2022 | 543.44 Mn |
| Sep 30, 2022 | 540.71 Mn |
| Jun 30, 2022 | 537.96 Mn |
| Mar 31, 2022 | -502.76 Mn |
| Dec 31, 2021 | -498.68 Mn |
| Sep 30, 2021 | 530.02 Mn |
| Jun 30, 2021 | 527.29 Mn |